15h
From festering infections to untreated cancer, ICE detainees across the US describe medical neglect
Immigrant detainees across at least 33 states allege in court documents that the government is failing to provide them with ...
Discusses Preliminary Phase I Data for SIM0505 in Platinum-Resistant Ovarian Cancer and Uterine Serous Carcinoma June 2, 2026 8:00 ...
As global oncology races toward next-generation therapies, Avammune Therapeutics is betting on affordable, orally ...
Dr. Maurie Markman, joins The Moonlight Shift to discuss precision medicine's real-world limits, oncology's cost crisis, ...
Aglatimagene is an investigational therapy that uses a modified virus to deliver a cancer-fighting gene into tumor cells.
Two Phase 3 multicenter trials of OCS-01 (OPTIREACH-enabled topical dexamethasone 15 mg/mL) missed 52-week BCVA and ≥15-letter gain endpoints, prompting abandonment of an FDA NDA for DME. Dosing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results